Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 78Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Leukemia, Lymphocytic, Chronic, B-Cell 70Myelodysplastic Syndromes 64Hodgkin Disease 63Multiple Myeloma 59Lymphoma, Non-Hodgkin 58Leukemia 53Lymphoma, Follicular 44Lymphoma, Mantle-Cell 43Lymphoma, Large B-Cell, Diffuse 41Lymphoma 41Myeloproliferative Disorders 39Lymphoma, B-Cell, Marginal Zone 37Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37Leukemia, Myeloid, Chronic-Phase 35Congenital Abnormalities 35Burkitt Lymphoma 33Lymphoma, Large-Cell, Immunoblastic 30Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Accelerated Phase 27Waldenstrom Macroglobulinemia 25Anemia, Refractory, with Excess of Blasts 25Hematologic Neoplasms 23Graft vs Host Disease 21Recurrence 20Dendritic Cell Sarcoma, Interdigitating 20Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 19Blast Crisis 19

Interventions

thymoglobulin 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neural Tube Defects × Mycophenolic Acid × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡